For Ovarian Cancer Awareness Month 2021, Ovacome member Katie wanted to raise awareness of the impact of an ovarian cancer diagnosis for all those whose lives are touched by the disease. As well as sharing her own story, Katie wanted to share the stories and perspectives of those who have supported her throughout her diagnosis and treatment - in their own words. In this video, Katie's oncologist Dr Susana Banerjee (MBBS MA PhD FRCP), consultant medical oncologist and research lead for the Gynaecology Unit at The Royal Marsden, shares her perspective.

GOG-3052 | ENGOT-ov60 CLINICAL TRIAL REVIEW

In this episode of the IJGC, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Susana Banerjee to discuss SOLO1. Dr. Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is also a Reader in Women’s Cancers at the Institute of Cancer Research. Dr. Banerjee specializes in ovarian cancer and the systemic treatment of endometrial and cervical cancers.

Dr Susana Banerjee, Dr Nuria Porta and clinical trial participant, Sally, describe the ATARI trial; testing a targeted therapy for relapsed rare gynaecological cancers.